Mumbai, March 2 -- Cipla (Jiangsu) Pharmaceutical Co. is a subsidiary of the company. The inspection has been concluded with zero Form 483 observations, stated the drug maker.

Meanwhile, the pharma company stated that the joint venture (JV) agreement entered between Cipla (EU) (wholly owned subsidiary of the company in UK) with Kemwell Biopharma UK and MNI Ventures have received confirmation of incorporation of JV 'MKC Biotherapeutics Inc.' from Secretary of State, Delaware, USA on 29 February 2024. The effective date of incorporation is 27 February 2024.

Further, Cipla informed that it has completed the transfer of Generics Business Undertaking as a going concern on a slump sale basis to Cipla Pharma and Life Sciences, a wholly owned s...